UPDATE 2-Crescent Point's loss bigger than expected as production falls
Feb 23 Canada's Crescent Point Energy Corp reported a bigger-than-expected quarterly loss on Thursday as the company's production fell about 6 percent.
Dec 19 Theravance Biopharma Inc :
* Theravance Biopharma highlights initiation of phase 3 study of the closed triple in patients with asthma by glaxosmithkline and innoviva
* Theravance Biopharma Inc - additionally, theravance biopharma is not responsible for any costs related to closed triple
* Theravance Biopharma - should closed triple be approved, commercialized, co is entitled to receive an 85% economic interest in royalties paid by gsk on worldwide net sales Source text for Eikon: Further company coverage:
NEW YORK, Feb 23 US Collateralized Loan Obligation (CLO) debt investors are receiving some of the lowest coupons since 2013, helping to counter a massive loan repricing wave, which should boost the issuance of new funds.
Feb 23 An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said.